330 related articles for article (PubMed ID: 3922757)
1. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
3. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
Raghavan S; Krusell A; Lyerla TA; Bremer EG; Kolodny EH
Biochim Biophys Acta; 1985 Apr; 834(2):238-48. PubMed ID: 3995063
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of GM2-activator protein. A study on its biosynthesis in human skin fibroblasts.
Burg J; Banerjee A; Sandhoff K
Biol Chem Hoppe Seyler; 1985 Sep; 366(9):887-91. PubMed ID: 3935131
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of ganglioside-amides in cultured human fibroblasts.
Klein D; Pohlentz G; Hinrichs U; Sandhoff K
Biol Chem Hoppe Seyler; 1987 Nov; 368(11):1495-503. PubMed ID: 3124867
[TBL] [Abstract][Full Text] [Related]
7. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
8. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
9. Canine GM2-gangliosidosis: chemical and enzymatic features.
Eto Y; Autilio-Gambetti L; McGrath JT
Adv Exp Med Biol; 1984; 174():431-40. PubMed ID: 6234761
[TBL] [Abstract][Full Text] [Related]
10. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
Ishikawa Y; Li SC; Wood PA; Li YT
J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
[TBL] [Abstract][Full Text] [Related]
11. GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient.
Sakuraba H; Itoh K; Shimmoto M; Utsumi K; Kase R; Hashimoto Y; Ozawa T; Ohwada Y; Imataka G; Eguchi M; Furukawa T; Schepers U; Sandhoff K
Neurology; 1999 Jan; 52(2):372-7. PubMed ID: 9932959
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activities in human skin fibroblasts preloaded with labeled GM2-ganglioside.
Raghavan S; Lyerla TA; Krusell A; Kolodny EH
Biochim Biophys Acta; 1987 Jan; 917(1):42-7. PubMed ID: 3098297
[TBL] [Abstract][Full Text] [Related]
13. [Identification of GM2-gangliosidosis using an in vitro loading test].
Akhunov VS; Krasnopol'skaia KD
Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
[TBL] [Abstract][Full Text] [Related]
14. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
Akhunov VS; Mirenburg TV; Krasnopolskaya XD
J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical abnormalities in porcine GM2-gangliosidosis.
Kosanke SD; Pierce KR; Bay WW
Vet Pathol; 1978 Nov; 15(6):685-99. PubMed ID: 108843
[No Abstract] [Full Text] [Related]
17. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
Conzelmann E; Burg J; Stephan G; Sandhoff K
Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
[TBL] [Abstract][Full Text] [Related]
18. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
20. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
